LeonaBio presents ALS drug at development summit, plans phase 2 trial Jun 4, 2026 07:01AM
Piper Sandler Starts LeonaBio (LONA) at Overweight May 27, 2026 03:46AM
LeonaBio adds three directors to board, John Fluke retires May 7, 2026 09:20AM
LeonaBio (LONA) Reiterated at Overweight by Cantor Fitzgerald Amid Growing Investor Interest Apr 7, 2026 07:15AM
LeonaBio (LONA) PT Raised to $16 at Mizuho Apr 6, 2026 06:43AM


Feb 26, 2026 06:32AM Cantor Fitzgerald Starts LeonaBio (LONA) at Overweight
Feb 18, 2026 04:36PM Mizuho Upgrades LeonaBio (LONA) to Outperform
Feb 3, 2026 07:00AM LeonaBio names Mark Kubik as chief business officer
Jan 20, 2026 04:44PM LeonaBio (LONA) files for 5.5M share offering by selling stockholders
Jan 20, 2026 04:26PM LeonaBio (LONA) files for 58.46M share offering by selling stockholders